pHR_PGK_antiCD19_synNotch_Gal4VP64 Citations (23)
Originally described in: Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors.Morsut L, Roybal KT, Xiong X, Gordley RM, Coyle SM, Thomson M, Lim WA Cell. 2016 Feb 11;164(4):780-91. doi: 10.1016/j.cell.2016.01.012. Epub 2016 Jan 28. PubMed Journal
Articles Citing pHR_PGK_antiCD19_synNotch_Gal4VP64
Showing 1 to 10 of 23 entries
Articles |
---|
Articles |
---|
Expression of modified FcgammaRI enables myeloid cells to elicit robust tumor-specific cytotoxicity. Farhat-Younis L, Na M, Zarfin A, Khateeb A, Santana-Magal N, Richter A, Gutwillig A, Rasoulouniriana D, Gleiberman A, Beck L, Giger T, Ashkenazi A, Barzel A, Rider P, Carmi Y. Elife. 2024 Jun 17;12:RP91999. doi: 10.7554/eLife.91999. PubMed |
A synthetic notch (synNotch) system linking intratumoral immune-cancer cell communication to a synthetic blood biomarker assay. Fu Y, Wang T, Ronald JA. Front Pharmacol. 2023 Dec 7;14:1304194. doi: 10.3389/fphar.2023.1304194. eCollection 2023. PubMed |
A CRISPR activation screen identifies MUC-21 as critical for resistance to NK and T cell-mediated cytotoxicity. Lee DH, Ahn H, Sim HI, Choi E, Choi S, Jo Y, Yun B, Song HK, Oh SJ, Denda-Nagai K, Park CS, Irimura T, Park Y, Jin HS. J Exp Clin Cancer Res. 2023 Oct 20;42(1):272. doi: 10.1186/s13046-023-02840-9. PubMed |
EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cells. Melo V, Nelemans LC, Vlaming M, Lourens HJ, Wiersma VR, Bilemjian V, Huls G, de Bruyn M, Bremer E. Front Immunol. 2023 Jul 20;14:1191866. doi: 10.3389/fimmu.2023.1191866. eCollection 2023. PubMed |
Post-translational covalent assembly of CAR and synNotch receptors for programmable antigen targeting. Ruffo E, Butchy AA, Tivon Y, So V, Kvorjak M, Parikh A, Adams EL, Miskov-Zivanov N, Finn OJ, Deiters A, Lohmueller J. Nat Commun. 2023 May 9;14(1):2463. doi: 10.1038/s41467-023-37863-5. PubMed |
Visualizing cell-cell communication using synthetic notch activated MRI. Wang T, Chen Y, Nystrom NN, Liu S, Fu Y, Martinez FM, Scholl TJ, Ronald JA. Proc Natl Acad Sci U S A. 2023 Mar 14;120(11):e2216901120. doi: 10.1073/pnas.2216901120. Epub 2023 Mar 9. PubMed |
Co-opting signalling molecules enables logic-gated control of CAR T cells. Tousley AM, Rotiroti MC, Labanieh L, Rysavy LW, Kim WJ, Lareau C, Sotillo E, Weber EW, Rietberg SP, Dalton GN, Yin Y, Klysz D, Xu P, de la Serna EL, Dunn AR, Satpathy AT, Mackall CL, Majzner RG. Nature. 2023 Mar;615(7952):507-516. doi: 10.1038/s41586-023-05778-2. Epub 2023 Mar 8. PubMed |
Enhancing adoptive T-cell therapy with fucoidan-based IL-2 delivery microcapsules. Jeon EY, Choi DS, Choi S, Won JY, Jo Y, Kim HB, Jung Y, Shin SC, Min H, Choi HW, Lee MS, Park Y, Chung JJ, Jin HS. Bioeng Transl Med. 2022 Jul 5;8(1):e10362. doi: 10.1002/btm2.10362. eCollection 2023 Jan. PubMed |
Engineering inducible biomolecular assemblies for genome imaging and manipulation in living cells. Peng Q, Huang Z, Sun K, Liu Y, Yoon CW, Harrison RES, Schmitt DL, Zhu L, Wu Y, Tasan I, Zhao H, Zhang J, Zhong S, Chien S, Wang Y. Nat Commun. 2022 Dec 24;13(1):7933. doi: 10.1038/s41467-022-35504-x. PubMed |
Targeting SARS-CoV-2 infection through CAR-T-like bispecific T cell engagers incorporating ACE2. Dogan M, Kozhaya L, Placek L, Karabacak F, Yigit M, Unutmaz D. Clin Transl Immunology. 2022 Oct 21;11(10):e1421. doi: 10.1002/cti2.1421. eCollection 2022. PubMed |
If you have published an article using this material, please email us at help@addgene.org to have your article added to this page.